Effects of a new formulation of olopatadine ophthalmic solution on nasal symptoms relative to placebo in two studies involving subjects with allergic conjunctivitis or rhinoconjunctivitis

By Abelson Mark B.   Gomes Paul J.   Vogelson Cullen T.   Pasquine Terri A.   Turner F. Darell   Wells David T.   Robertson Stella M.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 683-692

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge

By Mah Francis S.   Rosenwasser Lanny J.   Townsend William D.   Greiner Jack V.   Bensch George  

Current Medical Research and Opinion, Vol. 23, Iss. 6, 2007-06 ,pp. : 1445-1452

Informa Healthcare

Access to resources Recommend Favorite

The safety and efficacy of alcaftadine 0.25%% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis

By Torkildsen Gail   Shedden Arthur  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 623-631

Informa Healthcare

Access to resources Recommend Favorite

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research

By Rosenwasser Lanny J.   O'Brien Terrence   Weyne Jonathan  

Current Medical Research and Opinion, Vol. 21, Iss. 9, 2005-09 ,pp. : 1377-1388

Informa Healthcare

Access to resources Recommend Favorite

Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with openangle glaucoma or ocular hypertension

By Franks Wendy    

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1643-1649

Informa Healthcare

Access to resources Recommend Favorite